{{Rsnum
|rsid=1959947
|Chromosome=14
|position=41054257
|Orientation=plus
|GMAF=0.3893
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LOC644919
|Gene_s=LOC644919
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 42.5 | 50.4
| HCB | 5.8 | 40.9 | 53.3
| JPT | 8.8 | 31.0 | 60.2
| YRI | 70.7 | 25.9 | 3.4
| ASW | 43.9 | 43.9 | 12.3
| CHB | 5.8 | 40.9 | 53.3
| CHD | 7.3 | 33.9 | 58.7
| GIH | 3.0 | 39.6 | 57.4
| LWK | 60.9 | 35.5 | 3.6
| MEX | 10.3 | 37.9 | 51.7
| MKK | 38.5 | 48.1 | 13.5
| TSI | 6.9 | 31.4 | 61.8
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22443383
|Trait=None
|Title=Genome wide association study for plasma levels of natural anticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project.
|RiskAllele=A
|Pval=0.000007
|OR=4.7600
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}